fluconazole has been researched along with Keratitis in 48 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Keratitis: Inflammation of the cornea.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study was aimed at evaluating the treatment of fungal keratitis using a combination therapy of a low concentration of topical amphotericin B (0." | 9.14 | Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. ( Alswad, MM; Kader, MA; Mahdy, RA; Nada, WM; Saleh, MM; Wageh, MM, 2010) |
| "A prospective clinical trial of topical fluconazole solution (2 mg/ml) was undertaken in six consecutive eyes of microbiologically proven Candida keratitis with abscess formation." | 9.08 | Topical fluconazole therapy of Candida keratitis. ( Angra, SK; Panda, A; Sharma, N, 1996) |
| "2% fluconazole for the treatment of fungal keratitis." | 7.79 | Combined application of 5% natamycin and 0.2% fluconazole for the treatment of fungal keratitis. ( Gong, H; Gong, X, 2013) |
| "To evaluate the efficacy of subconjunctival injection of micafungin in the treatment of experimental Candida albicans keratitis in rabbits compared with fluconazole." | 7.74 | Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits. ( Hiraoka, T; Kaji, Y; Nanbu, PN; Okamoto, F; Oshika, T; Wakabayashi, T, 2007) |
| "To assess the efficacy and safety of subconjunctival fluconazole treatment as an alternative therapy for severe fungal keratitis refractory to the conventional antifungal medical treatment." | 7.73 | Severe fungal keratitis treated with subconjunctival fluconazole. ( Maden, A; Yilmaz, S, 2005) |
| "To investigate the therapeutic role of topical and oral fluconazole treatment using a rabbit model of Aspergillus fumigatus keratitis." | 7.72 | Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis. ( Avunduk, AM; Beuerman, RW; Greer, D; Kaufman, HE; Warnel, ED, 2003) |
| "Using a reproducible model of Candida albicans keratitis in rabbits we studied the effect of topical fluconazole, a new triazole." | 7.68 | Topical fluconazole for experimental candida keratitis in rabbits. ( Behrens-Baumann, W; Klinge, B; Rüchel, R, 1990) |
| "Alternaria keratitis has a varied clinical presentation and may present without macroscopic pigmentation." | 5.35 | Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin. ( Tu, EY, 2009) |
| "Fungal keratitis is a rare but serious condition that may result in loss of vision." | 5.33 | Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis. ( Ayala-Lugo, R; Barbosa, L; de Kaspar, HM; Sanchez-Di Martino, D; Sonego-Krone, S; Ta, CN; Torres-Alvariza, G, 2006) |
| "The study was aimed at evaluating the treatment of fungal keratitis using a combination therapy of a low concentration of topical amphotericin B (0." | 5.14 | Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis. ( Alswad, MM; Kader, MA; Mahdy, RA; Nada, WM; Saleh, MM; Wageh, MM, 2010) |
| "Combination therapy of topical amphotericin B eye drops with subconjunctival injection of fluconazole was more efficient (according to the percentage and the duration of healing of the ulcers) than the use of topical amphotericin B eye drops alone in dealing with cases of fungal keratitis--it may be contributed to the broad spectrum of the antifungal agents of the combination therapy than the monotherapy." | 5.14 | Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis. ( Mahdy, RA; Nada, WM; Wageh, MM, 2010) |
| "A prospective clinical trial of topical fluconazole solution (2 mg/ml) was undertaken in six consecutive eyes of microbiologically proven Candida keratitis with abscess formation." | 5.08 | Topical fluconazole therapy of Candida keratitis. ( Angra, SK; Panda, A; Sharma, N, 1996) |
| "CXL with riboflavin has become a common procedure to prevent keratoconus progression by strengthening the biomechanical specialties of the cornea." | 4.31 | Fungal Keratitis and Corneal Perforation as a Rare Complication of Corneal Collagen Cross-Linking Treatment. ( Barut Selver, O; Dogen, A; Hilmioglu Polat, S; Metin, DY; Palamar, M, 2023) |
| "2% fluconazole for the treatment of fungal keratitis." | 3.79 | Combined application of 5% natamycin and 0.2% fluconazole for the treatment of fungal keratitis. ( Gong, H; Gong, X, 2013) |
| "To study the clinical effect of a topical controlled-release ophthalmic fluconazole liposomal formulation on patients with Candida keratitis." | 3.78 | A new long-acting liposomal topical antifungal formula: human clinical study. ( Abdel-Rhaman, MS; Fathalla, D; Habib, F; Soliman, W, 2012) |
| "To evaluate the efficacy of subconjunctival injection of micafungin in the treatment of experimental Candida albicans keratitis in rabbits compared with fluconazole." | 3.74 | Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits. ( Hiraoka, T; Kaji, Y; Nanbu, PN; Okamoto, F; Oshika, T; Wakabayashi, T, 2007) |
| "To assess the efficacy and safety of subconjunctival fluconazole treatment as an alternative therapy for severe fungal keratitis refractory to the conventional antifungal medical treatment." | 3.73 | Severe fungal keratitis treated with subconjunctival fluconazole. ( Maden, A; Yilmaz, S, 2005) |
| "In an established Candida albicans murine keratitis model, combination therapy with ophthalmic preparations of fluconazole and cyclosporine A (CsA) demonstrated in vivo drug synergy and effectively resolved wild-type C." | 3.73 | Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy. ( Afshari, NA; Heitman, J; Onyewu, C, 2006) |
| "To determine the most efficient time point and concentration of topical corticosteroids in Candida albicans keratitis treated with fluconazole." | 3.72 | Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis. ( Behrens-Baumann, W; König, W; Olbrisch, A; Schreiber, W; Vorwerk, CK, 2003) |
| "To investigate the therapeutic role of topical and oral fluconazole treatment using a rabbit model of Aspergillus fumigatus keratitis." | 3.72 | Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis. ( Avunduk, AM; Beuerman, RW; Greer, D; Kaufman, HE; Warnel, ED, 2003) |
| "Topical fluconazole can be used as a topical antifungal agent to treat keratitis and needs further evaluation for treating fungal endophthalmitis." | 3.71 | [Pharmacokinetics of topically applied fluconazole in the rabbit eye]. ( Chen, Z; Xie, L; Zhang, J; Zhang, Q, 2002) |
| "Cysts of 2 isolates of Acanthamoeba from the cornea of 2 patients with confirmed Acanthamoeba keratitis were tested in vitro for sensitivity to antimycotic agents such as fluconazole, miconazole, amphotericin-B, pimaricin, antiprotozoal agents such as pentamidine isetionate and antiseptics which could be use in the ophthamological region." | 3.69 | [Evaluation of effective treatment drugs against Acanthamoeba cyst]. ( Asari, S; Endo, T; Shimomura, Y; Tahara, K; Yanagihara, T, 1997) |
| "Using a reproducible model of Candida albicans keratitis in rabbits we studied the effect of topical fluconazole, a new triazole." | 3.68 | Topical fluconazole for experimental candida keratitis in rabbits. ( Behrens-Baumann, W; Klinge, B; Rüchel, R, 1990) |
| "Alternaria keratitis has a varied clinical presentation and may present without macroscopic pigmentation." | 1.35 | Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin. ( Tu, EY, 2009) |
| "Infectious scleritis is a particular risk in cases involving diabetes mellitus, prior scleritis, previous surgery, and immunosuppression." | 1.34 | Paecilomyces lilacinus scleritis with secondary keratitis. ( Chung, PC; Hsiao, CH; Huang, SC; Hwang, YS; Lin, HC; Ngan, KW; Tsai, YJ, 2007) |
| "Fungal keratitis is a rare but serious condition that may result in loss of vision." | 1.33 | Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis. ( Ayala-Lugo, R; Barbosa, L; de Kaspar, HM; Sanchez-Di Martino, D; Sonego-Krone, S; Ta, CN; Torres-Alvariza, G, 2006) |
| "Fusarium solani was cultured from the initial vitrectomy specimen in patient 1, and although it was not cultured from the keratitis, septate hyphal elements were present on histopathologic examination." | 1.30 | Delayed-onset fungal keratitis after endophthalmitis. ( Eagle, RC; Frayer, WC; Orlin, SE; Sulewski, ME; Weissgold, DJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (20.83) | 18.2507 |
| 2000's | 20 (41.67) | 29.6817 |
| 2010's | 13 (27.08) | 24.3611 |
| 2020's | 5 (10.42) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, K | 1 |
| Inoue, Y | 1 |
| Asari, S | 2 |
| Sunada, A | 1 |
| Ohashi, Y | 1 |
| Shimomura, Y | 2 |
| Sotozono, C | 1 |
| Hatano, H | 1 |
| Fukuda, M | 1 |
| Eguchi, H | 1 |
| Araki-Sasaki, K | 1 |
| Suzuki, T | 1 |
| Hoshi, S | 1 |
| Tobe, T | 1 |
| Yaguchi, T | 1 |
| Makimura, K | 1 |
| Sanap, SN | 1 |
| Bisen, AC | 1 |
| Kedar, A | 1 |
| Yadav, KS | 1 |
| Krishna, A | 1 |
| Akhir, A | 1 |
| Chopra, S | 1 |
| Mugale, MN | 1 |
| Bhatta, RS | 1 |
| Barut Selver, O | 1 |
| Metin, DY | 1 |
| Hilmioglu Polat, S | 1 |
| Dogen, A | 1 |
| Palamar, M | 1 |
| Fejes, I | 1 |
| Garcia-Hermosa, P | 1 |
| Bodin, A | 1 |
| Nasr, M | 1 |
| Teiama, M | 1 |
| Ismail, A | 1 |
| Ebada, A | 1 |
| Saber, S | 1 |
| Brilhante, RSN | 1 |
| Bittencourt, PV | 1 |
| de Souza Collares Castelo-Branco, D | 1 |
| de Melo Guedes, GM | 1 |
| de Oliveira, JS | 1 |
| Alencar, LP | 1 |
| de Aguiar Cordeiro, R | 1 |
| Pinheiro, M | 1 |
| Nogueira-Filho, EF | 1 |
| de Aquino Pereira-Neto, W | 1 |
| Sidrim, JJC | 1 |
| Rocha, MFG | 1 |
| Ali Shah, SI | 1 |
| Shah, SA | 1 |
| Rai, P | 1 |
| Katpar, NA | 1 |
| Abbasi, SA | 1 |
| Soomro, AA | 1 |
| Bartenstein, D | 1 |
| Chung, HJ | 1 |
| Hussain, S | 1 |
| Saud Al-Abbas, AH | 1 |
| Ling, JL | 1 |
| Muhammed, J | 1 |
| Hussein, A | 1 |
| Gong, H | 1 |
| Gong, X | 1 |
| Samudio, M | 1 |
| Laspina, F | 1 |
| Fariña, N | 1 |
| Franco, A | 1 |
| Mino de Kaspar, H | 2 |
| Giusiano, G | 1 |
| Phan, CM | 1 |
| Bajgrowicz, M | 1 |
| McCanna, DJ | 1 |
| Subbaraman, LN | 1 |
| Jones, L | 1 |
| Tu, EY | 1 |
| Mahdy, RA | 2 |
| Nada, WM | 2 |
| Wageh, MM | 2 |
| Kader, MA | 1 |
| Saleh, MM | 1 |
| Alswad, MM | 1 |
| Böhm, MR | 1 |
| Prokosch, V | 1 |
| Merté, RL | 1 |
| Koch, R | 1 |
| Busse, H | 1 |
| Stupp, T | 1 |
| Gajjar, DU | 1 |
| Pal, AK | 1 |
| Parmar, TJ | 1 |
| Arora, AI | 1 |
| Ganatra, DA | 1 |
| Kayastha, FB | 1 |
| Ghodadra, BK | 1 |
| Vasavada, AR | 1 |
| Abdel-Rhaman, MS | 1 |
| Soliman, W | 1 |
| Habib, F | 1 |
| Fathalla, D | 1 |
| Machan, M | 1 |
| Kestenbaum, T | 1 |
| Fraga, GR | 1 |
| Avunduk, AM | 2 |
| Beuerman, RW | 2 |
| Varnell, ED | 1 |
| Kaufman, HE | 2 |
| Yao, YF | 1 |
| Zhang, YM | 1 |
| Zhou, P | 1 |
| Zhang, B | 1 |
| Qiu, WY | 1 |
| Tseng, SC | 1 |
| Richter, M | 1 |
| Hauser, B | 1 |
| Kaps, S | 1 |
| Spiess, BM | 1 |
| Schreiber, W | 1 |
| Olbrisch, A | 1 |
| Vorwerk, CK | 1 |
| König, W | 1 |
| Behrens-Baumann, W | 2 |
| Warnel, ED | 1 |
| Greer, D | 1 |
| Saracli, MA | 1 |
| Erdem, U | 1 |
| Gonlum, A | 1 |
| Yildiran, ST | 1 |
| Solomon, R | 1 |
| Biser, SA | 1 |
| Donnenfeld, ED | 1 |
| Perry, HD | 1 |
| Doshi, SJ | 1 |
| Lee, CC | 1 |
| Lin, CP | 1 |
| Chang, CW | 1 |
| Su, CY | 1 |
| Yilmaz, S | 1 |
| Maden, A | 1 |
| Sonego-Krone, S | 1 |
| Sanchez-Di Martino, D | 1 |
| Ayala-Lugo, R | 1 |
| Torres-Alvariza, G | 1 |
| Ta, CN | 1 |
| Barbosa, L | 1 |
| de Kaspar, HM | 1 |
| Dev, S | 1 |
| Rajaraman, R | 1 |
| Raghavan, A | 1 |
| Onyewu, C | 1 |
| Afshari, NA | 1 |
| Heitman, J | 1 |
| Therese, KL | 1 |
| Bagyalakshmi, R | 1 |
| Madhavan, HN | 2 |
| Deepa, P | 1 |
| Chung, PC | 1 |
| Lin, HC | 1 |
| Hwang, YS | 1 |
| Tsai, YJ | 1 |
| Ngan, KW | 1 |
| Huang, SC | 1 |
| Hsiao, CH | 1 |
| Hiraoka, T | 1 |
| Kaji, Y | 1 |
| Wakabayashi, T | 1 |
| Nanbu, PN | 1 |
| Okamoto, F | 1 |
| Oshika, T | 1 |
| Shiraishi, S | 1 |
| Murakami, S | 1 |
| Miki, Y | 1 |
| Lund, OE | 1 |
| Klauss, V | 1 |
| Panda, A | 1 |
| Sharma, N | 1 |
| Angra, SK | 1 |
| Koç, AN | 1 |
| Erkiliç, K | 1 |
| Evrensel, N | 1 |
| Coşkun, A | 1 |
| Tahara, K | 1 |
| Endo, T | 1 |
| Yanagihara, T | 1 |
| Rao, SK | 1 |
| Rao, G | 1 |
| Padmanabhan, P | 1 |
| Weissgold, DJ | 1 |
| Orlin, SE | 1 |
| Sulewski, ME | 1 |
| Frayer, WC | 1 |
| Eagle, RC | 1 |
| Yamamoto, N | 1 |
| Matsumoto, T | 1 |
| Ishibashi, Y | 1 |
| Shin, JY | 1 |
| Kim, HM | 1 |
| Hong, JW | 1 |
| Zhang, J | 1 |
| Xie, L | 1 |
| Chen, Z | 1 |
| Zhang, Q | 1 |
| Wu, Z | 1 |
| Ying, H | 1 |
| Yiu, S | 1 |
| Irvine, J | 1 |
| Smith, R | 1 |
| O'Day, DM | 2 |
| Head, WS | 1 |
| Robinson, RD | 1 |
| Williams, TE | 1 |
| Gedde, S | 1 |
| Klinge, B | 1 |
| Rüchel, R | 1 |
3 reviews available for fluconazole and Keratitis
| Article | Year |
|---|---|
Keratitis Caused by Candida parapsilosis and Subsequent Corynebacterium macginleyi Infection: Case Report and Short Review.
Topics: Aged; Anti-Bacterial Agents; Antifungal Agents; Candida parapsilosis; Candidiasis; Ciprofloxacin; Co | 2020 |
[Keratitis by Lasiodiplodia theobromae: a case report and literature review].
Topics: Ascomycota; Eye Infections, Fungal; Fluconazole; Fluoroquinolones; Humans; Keratitis; Male; Middle A | 2014 |
Fungal keratitis caused by Scedosporium apiospermum: report of two cases and review of treatment.
Topics: Adult; Aged; Amphotericin B; Cornea; Corneal Injuries; Drug Therapy, Combination; Eye Enucleation; E | 2002 |
3 trials available for fluconazole and Keratitis
| Article | Year |
|---|---|
Assessment safety and efficacy of a combination therapy of topical amphotericin B and subconjunctival fluconazole for the treatment of fungal keratitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Conjunctiva; Corneal Ulcer; Dru | 2010 |
Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Conjun | 2010 |
Topical fluconazole therapy of Candida keratitis.
Topics: Abscess; Administration, Topical; Adolescent; Adult; Aged; Candidiasis; Child; Corneal Diseases; Fem | 1996 |
42 other studies available for fluconazole and Keratitis
| Article | Year |
|---|---|
Multicenter prospective observational study of fungal keratitis in Japan: analyses of in vitro susceptibility tests for combinations of drugs.
Topics: Antifungal Agents; Azoles; Eye Infections, Fungal; Fluconazole; Fungi; Humans; Japan; Keratitis; Sac | 2022 |
Chitosan/HPMC-based mucoadhesive film co-loaded with fluconazole and ofloxacin for management of polymicrobial keratitis.
Topics: Chitosan; Drug Compounding; Drug Delivery Systems; Fluconazole; Humans; Keratitis; Ofloxacin | 2022 |
Fungal Keratitis and Corneal Perforation as a Rare Complication of Corneal Collagen Cross-Linking Treatment.
Topics: Adult; Corneal Cross-Linking; Corneal Perforation; Corneal Ulcer; Cross-Linking Reagents; Eye Infect | 2023 |
In vitro and in vivo evaluation of cubosomal nanoparticles as an ocular delivery system for fluconazole in treatment of keratomycosis.
Topics: Animals; Antifungal Agents; Cornea; Drug Delivery Systems; Eye Infections, Fungal; Fluconazole; Kera | 2020 |
Biofilms of Candida spp. from the ocular conjunctiva of horses with reduced azole susceptibility: a complicating factor for the treatment of keratomycosis?
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Biofilms; Candida; Caspofungin; Conjunctiva; Ech | 2017 |
Visual outcome in patients of keratomycosis, at a tertiary care centre in Larkana, Pakistan.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Corneal Transplantation; Eye Infections, Fungal; Flucona | 2017 |
Two Cases of Chronic Candidiasis in Keratitis-Ichthyosis-Deafness Syndrome.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Biopsy; Candidiasis, Cutaneous; Chronic | 2018 |
Rare
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Cornea; Corneal Injuries; Corneal Stroma | 2019 |
Combined application of 5% natamycin and 0.2% fluconazole for the treatment of fungal keratitis.
Topics: Administration, Topical; Antifungal Agents; Drug Therapy, Combination; Eye Infections, Fungal; Femal | 2013 |
Effects of Antifungal Soaked Silicone Hydrogel Contact Lenses on Candida albicans in an Agar Eye Model.
Topics: Agar; Antifungal Agents; Candida albicans; Candidiasis; Contact Lenses, Hydrophilic; Drug Delivery S | 2016 |
Alternaria keratitis: clinical presentation and resolution with topical fluconazole or intrastromal voriconazole and topical caspofungin.
Topics: Administration, Topical; Adult; Aged; Alternaria; Antifungal Agents; Caspofungin; Cataract Extractio | 2009 |
[Microbiological analysis in contact lens-associated keratits].
Topics: Acanthamoeba Keratitis; Adolescent; Adult; Anterior Eye Segment; Anti-Bacterial Agents; Antifungal A | 2011 |
Fungal scleral keratitis caused by Phomopsis phoenicicola.
Topics: Antifungal Agents; Ascomycota; DNA, Fungal; DNA, Ribosomal Spacer; Fluconazole; Humans; Keratitis; M | 2011 |
A new long-acting liposomal topical antifungal formula: human clinical study.
Topics: Administration, Topical; Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis; Eye Infectio | 2012 |
Diffuse hyperkeratosis in a deaf and blind 48-year-old woman--quiz case. Diagnosis: keratitis-ichthyosis-deafness (KID) syndrome with secondary dermatophytosis.
Topics: Antifungal Agents; Baths; Blindness; Deafness; Dermatologic Agents; Female; Fluconazole; Humans; Ich | 2012 |
Confocal microscopy of Aspergillus fumigatus keratitis.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Aspergillosis; Aspergillu | 2003 |
Therapeutic penetrating keratoplasty in severe fungal keratitis using cryopreserved donor corneas.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Cornea; Cryopreservation; Eye Infections, Fung | 2003 |
Keratitis due to Histoplasma spp. in a horse.
Topics: Animals; Antifungal Agents; Diagnosis, Differential; Fluconazole; Histoplasma; Histoplasmosis; Horse | 2003 |
Combined topical fluconazole and corticosteroid treatment for experimental Candida albicans keratomycosis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Conjunctivitis; Cornea; Disease Models, A | 2003 |
Comparison of efficacy of topical and oral fluconazole treatment in experimental Aspergillus keratitis.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Aspergillosis; Aspergillu | 2003 |
Scedosporium apiospermum keratitis treated with itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Eye Infections, Fungal; Fluconazo | 2003 |
Candida parapsilosis keratitis following treatment of epithelial ingrowth after laser in situ keratomileusis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Drug Therapy, Combination; Epithelium, | 2004 |
Phototherapeutic keratectomy in treating keratomycosis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Child; Corne | 2005 |
Severe fungal keratitis treated with subconjunctival fluconazole.
Topics: Adult; Aged; Antifungal Agents; Conjunctiva; Eye Infections, Fungal; Female; Fluconazole; Humans; In | 2005 |
Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Drug The | 2006 |
Severe fungal keratitis treated with subconjunctival fluconazole.
Topics: Antifungal Agents; Conjunctiva; Eye Infections, Fungal; Fluconazole; Humans; Injections; Keratitis; | 2006 |
Calcineurin promotes infection of the cornea by Candida albicans and can be targeted to enhance fluconazole therapy.
Topics: Animals; Antifungal Agents; Calcineurin; Calcineurin Inhibitors; Candida albicans; Candidiasis; Corn | 2006 |
In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Eye Diseases; Fluc | 2006 |
Paecilomyces lilacinus scleritis with secondary keratitis.
Topics: Administration, Oral; Aged, 80 and over; Antifungal Agents; Debridement; Drug Therapy, Combination; | 2007 |
Comparison of micafungin and fluconazole for experimental Candida keratitis in rabbits.
Topics: Animals; Antifungal Agents; Candidiasis; Conjunctiva; Disease Models, Animal; Echinocandins; Eye Inf | 2007 |
Oral fluconazole treatment of fungating candidiasis in the keratitis, ichthyosis and deafness (KID) syndrome.
Topics: Administration, Oral; Candidiasis, Cutaneous; Deafness; Fluconazole; Follow-Up Studies; Humans; Icht | 1994 |
[Strategy for examination and therapy of mycotic keratitis].
Topics: Acremonium; Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Contact Lenses; Dru | 1993 |
A case of Alternaria keratitis treated with fluconazole.
Topics: Aged; Alternaria; Antifungal Agents; Cataract Extraction; Fluconazole; Humans; Keratitis; Male; Myco | 1997 |
[Evaluation of effective treatment drugs against Acanthamoeba cyst].
Topics: Acanthamoeba; Amphotericin B; Animals; Anti-Infective Agents, Local; Antifungal Agents; Antiprotozoa | 1997 |
Fluconazole in filamentous fungal keratitis.
Topics: Antifungal Agents; Cornea; Eye Infections, Fungal; Fluconazole; Humans; Keratitis; Mitosporic Fungi; | 1997 |
Delayed-onset fungal keratitis after endophthalmitis.
Topics: Acremonium; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cataract Extraction; Corneal | 1998 |
Fungal keratitis caused by Colletotrichum gloeosporioides.
Topics: Aged; Aged, 80 and over; Colletotrichum; Cornea; Eye Infections, Fungal; Fluconazole; Humans; Kerati | 2001 |
Keratitis caused by Verticillium species.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Eye Infections, Fungal; Fluconazole; H | 2002 |
[Pharmacokinetics of topically applied fluconazole in the rabbit eye].
Topics: Animals; Antifungal Agents; Aqueous Humor; Cornea; Epithelium, Corneal; Female; Fluconazole; Keratit | 2002 |
The evaluation of therapeutic responses in experimental keratomycosis.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Colony Count | 1992 |
Orally administered antifungal therapy for experimental keratomycosis.
Topics: Administration, Oral; Animals; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; | 1990 |
Topical fluconazole for experimental candida keratitis in rabbits.
Topics: Administration, Topical; Animals; Aqueous Humor; Biological Availability; Candidiasis; Cornea; Fluco | 1990 |